Home › Funds › CastleKnight Management LP › THC

CastleKnight Management LP position in THC

TENET HEALTHCARE CORP · Health Care

CastleKnight Management LP reported holding 66,100 shares of THC (TENET HEALTHCARE CORP) in its Q2 2026 13F filing — a position valued at US$12.4M, representing 0.35% of its reported portfolio and ranking #46 among its reported holdings. CastleKnight Management LP has disclosed THC holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)66.10K sh
Reported value held$12.37M
Portfolio Weight0.35%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How CastleKnight Management LP's THC position evolved

CastleKnight Management LP first disclosed a stake in THC in Q3 2023 at 78,400 shares (US$5.2M). The position peaked in Q3 2025 at 73,700 shares, worth US$15.0M. Across 12 filings, CastleKnight Management LP increased the stake 5 time(s), trimmed it 5 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 66,100 shares valued at US$12.4M — an increase of 36,100 shares quarter over quarter.. Notable position changes include a 266% increase in Q4 2024 (shares rose 7% over the following quarter), a 307% increase in Q1 2025 (shares rose 31% over the following quarter), a 120% increase in Q2 2026 (shares rose 37% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 78.40K $5.17M New
Q4 2023 40.00K $3.02M Reduce
Q1 2024 22.70K $2.39M Reduce
Q2 2024 6.10K $811.48K Reduce
Q3 2024 3.50K $581.70K Reduce
Q4 2024 12.80K $1.62M Add
Q1 2025 52.10K $7.01M Add
Q2 2025 67.90K $11.95M Add
Q3 2025 73.70K $14.96M Add
Q4 2025 30.00K $5.96M Reduce
Q1 2026 30.00K $5.66M Hold
Q2 2026 66.10K $12.37M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About THC and 13F data

THC (TENET HEALTHCARE CORP) is a Health Care company. 40 other funds we track also report a position in THC — the largest reported positions include Boston Partners (US$829.1M), GLENVIEW CAPITAL MANAGEMENT, LLC (US$418.2M), MANNING & NAPIER ADVISORS LLC (US$168.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding THC

All THC fund holders →

FAQ

How long has CastleKnight Management LP held THC?

CastleKnight Management LP has disclosed THC holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is CastleKnight Management LP's current position in THC?

As of Q2 2026, CastleKnight Management LP holds 66.10K shares of THC (TENET HEALTHCARE CORP), valued at $12.37M, representing 0.35% of its reported portfolio and ranking #46.

Has CastleKnight Management LP been buying or selling THC?

In the latest 13F filing (Q2 2026), CastleKnight Management LP increased its position in THC. The position peaked in Q3 2025 at 73.70K shares.

Which other funds hold THC?

Other major institutional holders of THC include Boston Partners, GLENVIEW CAPITAL MANAGEMENT, LLC, MANNING & NAPIER ADVISORS LLC, among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.